{"id":19764,"date":"2024-03-17T15:13:13","date_gmt":"2024-03-17T15:13:13","guid":{"rendered":"https:\/\/eavest.fr\/?post_type=eavestpedia&#038;p=19764"},"modified":"2025-05-16T12:36:24","modified_gmt":"2025-05-16T12:36:24","slug":"analyse-de-laction-sanofi","status":"publish","type":"eavestpedia","link":"https:\/\/eavest.fr\/en\/eavestpedia\/analyse-de-laction-sanofi\/","title":{"rendered":"Analyse de l\u2019action Sanofi"},"content":{"rendered":"<p>&nbsp;<\/p>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"wp-image-19777 aligncenter\" src=\"https:\/\/eavest.fr\/wp-content\/uploads\/2024\/07\/sanofi_niou-removebg-preview-300x246.png\" alt=\"\" width=\"355\" height=\"291\" srcset=\"https:\/\/eavest.fr\/wp-content\/uploads\/2024\/07\/sanofi_niou-removebg-preview-300x246.png 300w, https:\/\/eavest.fr\/wp-content\/uploads\/2024\/07\/sanofi_niou-removebg-preview.png 552w\" sizes=\"(max-width: 355px) 100vw, 355px\" \/><\/p>\n<h2 style=\"text-align: justify;\"><strong>Pr\u00e9sentation de Sanofi:<\/strong><\/h2>\n<div class=\"group\/conversation-turn relative flex w-full min-w-0 flex-col agent-turn\">\n<div class=\"flex-col gap-1 md:gap-3\">\n<div class=\"flex flex-grow flex-col max-w-full\">\n<div class=\"min-h-[20px] text-message flex w-full flex-col items-end gap-2 whitespace-pre-wrap break-words [.text-message+&amp;]:mt-5 overflow-x-auto\" dir=\"auto\" data-message-author-role=\"assistant\" data-message-id=\"62fa0d0e-a9ff-4607-a385-5842eaac0ab8\">\n<div class=\"flex w-full flex-col gap-1 empty:hidden first:pt-[3px]\">\n<div class=\"markdown prose w-full break-words dark:prose-invert dark\">\n<p>Sanofi est un leader mondial dans le domaine de la sant\u00e9 et des sciences de la vie. Fond\u00e9e en 1973, l\u2019entreprise est reconnue pour ses innovations pharmaceutiques et biotechnologiques. Sanofi propose une large gamme de produits et services, allant des m\u00e9dicaments de prescription aux solutions de sant\u00e9 grand public, attirant ainsi une client\u00e8le diversifi\u00e9e \u00e0 la recherche de solutions de sant\u00e9 fiables et innovantes. Pr\u00e9sente dans plus de 100 pays, l\u2019entreprise b\u00e9n\u00e9ficie d\u2019une client\u00e8le internationale fid\u00e8le, soutenue par ses 100 000 employ\u00e9s passionn\u00e9s et engag\u00e9s.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<h2 style=\"text-align: justify;\"><strong>Points cl\u00e9s :<\/strong><\/h2>\n<div class=\"flex flex-grow flex-col max-w-full\">\n<div class=\"min-h-[20px] text-message flex w-full flex-col items-end gap-2 whitespace-pre-wrap break-words [.text-message+&amp;]:mt-5 overflow-x-auto\" dir=\"auto\" data-message-author-role=\"assistant\" data-message-id=\"78d20ac6-f2d3-48cf-b8dd-ef49210aeb3b\">\n<div class=\"flex w-full flex-col gap-1 empty:hidden first:pt-[3px]\">\n<div class=\"markdown prose w-full break-words dark:prose-invert light\">\n<div class=\"flex-shrink-0 flex flex-col relative items-end\">\n<div class=\"pt-0\">\n<div class=\"gizmo-bot-avatar flex h-8 w-8 items-center justify-center overflow-hidden rounded-full\">\n<div class=\"relative p-1 rounded-sm flex items-center justify-center bg-token-main-surface-primary text-token-text-primary h-8 w-8\">\n<ul>\n<li data-start=\"141\" data-end=\"531\">En 2024, Sanofi a enregistr\u00e9 une progression solide de son chiffre d\u2019affaires annuel, atteignant 43,1 milliards d\u2019euros, en hausse de 4,1 % \u00e0 taux de change constants par rapport \u00e0 l\u2019ann\u00e9e pr\u00e9c\u00e9dente. Au quatri\u00e8me trimestre, le chiffre d\u2019affaires s\u2019est \u00e9tabli \u00e0 10,4 milliards d\u2019euros, marquant une croissance de 6,1 % \u00e0 taux constants par rapport au m\u00eame trimestre de 2023.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li data-start=\"141\" data-end=\"531\">Cette performance a \u00e9t\u00e9 port\u00e9e par la croissance soutenue de la franchise Dupixent, moteur principal de l\u2019activit\u00e9 immunologie, et par le succ\u00e8s des nouveaux lancements, notamment dans les maladies rares et les vaccins. Le segment des vaccins a \u00e9galement connu une progression, gr\u00e2ce \u00e0 la demande accrue pour Beyfortus et les vaccins p\u00e9diatriques.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li data-start=\"141\" data-end=\"531\">Les d\u00e9penses op\u00e9rationnelles ont \u00e9t\u00e9 ma\u00eetris\u00e9es tout au long de l\u2019ann\u00e9e, permettant \u00e0 Sanofi d\u2019atteindre un r\u00e9sultat op\u00e9rationnel des activit\u00e9s de 9,8 milliards d\u2019euros, en hausse de 6,4 % \u00e0 taux de change constants. Le cash-flow libre s\u2019est maintenu \u00e0 un niveau \u00e9lev\u00e9, \u00e0 plus de 5 milliards d\u2019euros. Le co\u00fbt du risque, non applicable directement au mod\u00e8le pharmaceutique, se refl\u00e8te dans une gestion prudente des investissements et des d\u00e9penses, notamment avec une marge op\u00e9rationnelle de 28,5 % en 2024, stable par rapport \u00e0 l\u2019ann\u00e9e pr\u00e9c\u00e9dente.<\/li>\n<\/ul>\n<\/div>\n<div class=\"relative p-1 rounded-sm flex items-center justify-center bg-token-main-surface-primary text-token-text-primary h-8 w-8\"><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h2><strong>Recommandations des analystes\u00a0:<\/strong><\/h2>\n<ul>\n<li><b>HSBC <\/b>maintient sa recommandation <span style=\"color: #008000;\"><b>d&#8217;achat<\/b> <\/span>avec un objectif de cours r\u00e9duit de <b>130 \u00e0 115 EUR.<\/b><\/li>\n<li><b>JP Morgan <\/b>a r\u00e9it\u00e9r\u00e9 son opinion <span style=\"color: #008000;\"><b>neutre<\/b> <\/span>sur le titre. L&#8217;objectif de cours continue d&#8217;\u00eatre situ\u00e9 \u00e0 <b>110 EUR.<\/b><\/li>\n<li><b>UBS <\/b>r\u00e9affirme sa recommandation <b><span style=\"color: #008000;\">d\u2019achat<\/span> <\/b>avec un objectif de cours ramen\u00e9 de <b>120 \u00e0 115 EUR. <\/b><\/li>\n<\/ul>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"wp-image-20837 size-full aligncenter\" src=\"https:\/\/eavest.fr\/wp-content\/uploads\/2024\/03\/sanofi.jpg\" alt=\"\" width=\"565\" height=\"243\" srcset=\"https:\/\/eavest.fr\/wp-content\/uploads\/2024\/03\/sanofi.jpg 565w, https:\/\/eavest.fr\/wp-content\/uploads\/2024\/03\/sanofi-300x129.jpg 300w\" sizes=\"(max-width: 565px) 100vw, 565px\" \/><\/p>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h2><strong>Dividendes et pr\u00e9visions :<\/strong><\/h2>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"wp-image-20839 size-full aligncenter\" src=\"https:\/\/eavest.fr\/wp-content\/uploads\/2024\/03\/Capture-decran-2025-05-15-150026.jpg\" alt=\"\" width=\"562\" height=\"298\" srcset=\"https:\/\/eavest.fr\/wp-content\/uploads\/2024\/03\/Capture-decran-2025-05-15-150026.jpg 562w, https:\/\/eavest.fr\/wp-content\/uploads\/2024\/03\/Capture-decran-2025-05-15-150026-300x159.jpg 300w\" sizes=\"(max-width: 562px) 100vw, 562px\" \/><\/p>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h2><strong>Cours de l\u2019action Sanofi au 15\/05\/2025 :<\/strong><\/h2>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"wp-image-20841 aligncenter\" title=\"Cours de l\u2019action BNP Paribas au 23\/07\/2024\" src=\"https:\/\/eavest.fr\/wp-content\/uploads\/2024\/03\/Capture-decran-2025-05-15-152211.png\" alt=\"\" width=\"666\" height=\"440\" srcset=\"https:\/\/eavest.fr\/wp-content\/uploads\/2024\/03\/Capture-decran-2025-05-15-152211.png 829w, https:\/\/eavest.fr\/wp-content\/uploads\/2024\/03\/Capture-decran-2025-05-15-152211-300x198.png 300w, https:\/\/eavest.fr\/wp-content\/uploads\/2024\/03\/Capture-decran-2025-05-15-152211-768x507.png 768w, https:\/\/eavest.fr\/wp-content\/uploads\/2024\/03\/Capture-decran-2025-05-15-152211-800x528.png 800w\" sizes=\"(max-width: 666px) 100vw, 666px\" \/><\/p>\n<p>&nbsp;<\/p>\n<hr \/>\n<p><strong><img decoding=\"async\" loading=\"lazy\" class=\"alignnone wp-image-18599\" src=\"https:\/\/eavest.fr\/wp-content\/uploads\/2023\/02\/Capture.jpg\" alt=\"\" width=\"27\" height=\"23\" \/>\u00a0\u00a0<span style=\"color: #ff0000;\">Avertissement :<\/span><\/strong><\/p>\n<p>Les donn\u00e9es relatives aux performances pass\u00e9es et\/ou simulations de performances pass\u00e9es ont trait ou se r\u00e9f\u00e8rent \u00e0 des p\u00e9riodes pass\u00e9es et ne sont pas un indicateur fiable des r\u00e9sultats futurs. Ceci est valable \u00e9galement pour les donn\u00e9es historiques de march\u00e9. Cette pr\u00e9sentation ne fait pas office de conseil en investissement.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.produitsensouscription.com\/?code=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\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" loading=\"lazy\" class=\"aligncenter wp-image-18775\" title=\"Premi\u00e8re marketplace de produits structur\u00e9s\" src=\"https:\/\/eavest.fr\/wp-content\/uploads\/2024\/03\/ELEMENTS_Plan-de-travail-1-copie.png\" alt=\"Premi\u00e8re marketplace de produits structur\u00e9s\" width=\"1000\" height=\"306\" srcset=\"https:\/\/eavest.fr\/wp-content\/uploads\/2024\/03\/ELEMENTS_Plan-de-travail-1-copie.png 3963w, https:\/\/eavest.fr\/wp-content\/uploads\/2024\/03\/ELEMENTS_Plan-de-travail-1-copie-300x92.png 300w, https:\/\/eavest.fr\/wp-content\/uploads\/2024\/03\/ELEMENTS_Plan-de-travail-1-copie-1024x313.png 1024w, https:\/\/eavest.fr\/wp-content\/uploads\/2024\/03\/ELEMENTS_Plan-de-travail-1-copie-768x235.png 768w, https:\/\/eavest.fr\/wp-content\/uploads\/2024\/03\/ELEMENTS_Plan-de-travail-1-copie-1536x470.png 1536w, https:\/\/eavest.fr\/wp-content\/uploads\/2024\/03\/ELEMENTS_Plan-de-travail-1-copie-2048x627.png 2048w, https:\/\/eavest.fr\/wp-content\/uploads\/2024\/03\/ELEMENTS_Plan-de-travail-1-copie-1900x582.png 1900w, https:\/\/eavest.fr\/wp-content\/uploads\/2024\/03\/ELEMENTS_Plan-de-travail-1-copie-1100x337.png 1100w, https:\/\/eavest.fr\/wp-content\/uploads\/2024\/03\/ELEMENTS_Plan-de-travail-1-copie-800x245.png 800w\" sizes=\"(max-width: 1000px) 100vw, 1000px\" \/><\/a><\/p>\n","protected":false},"featured_media":0,"template":"","meta":[],"sujet":[],"sous-categorie-titre":[],"_links":{"self":[{"href":"https:\/\/eavest.fr\/en\/wp-json\/wp\/v2\/eavestpedia\/19764\/"}],"collection":[{"href":"https:\/\/eavest.fr\/en\/wp-json\/wp\/v2\/eavestpedia\/"}],"about":[{"href":"https:\/\/eavest.fr\/en\/wp-json\/wp\/v2\/types\/eavestpedia\/"}],"wp:attachment":[{"href":"https:\/\/eavest.fr\/en\/wp-json\/wp\/v2\/media\/?parent=19764"}],"wp:term":[{"taxonomy":"sujet","embeddable":true,"href":"https:\/\/eavest.fr\/en\/wp-json\/wp\/v2\/sujet\/?post=19764"},{"taxonomy":"sous-categorie-titre","embeddable":true,"href":"https:\/\/eavest.fr\/en\/wp-json\/wp\/v2\/sous-categorie-titre\/?post=19764"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}